MAOI interaction — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Hypertensive crisis risk from sympathomimetic interaction
MAOIs interact dangerously with sympathomimetics such as pseudoephedrine. The sale should be avoided and safer options considered. In this scenario, the correct option is hypertensive crisis risk from sympathomimetic interaction. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.
Reference: BNF; Stockley's Drug Interactions